BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goell JH, Hilton IB. CRISPR/Cas-Based Epigenome Editing: Advances, Applications, and Clinical Utility. Trends Biotechnol 2021;39:678-91. [PMID: 33972106 DOI: 10.1016/j.tibtech.2020.10.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Escobar M, Li J, Patel A, Liu S, Xu Q, Hilton IB. Quantification of Genome Editing and Transcriptional Control Capabilities Reveals Hierarchies among Diverse CRISPR/Cas Systems in Human Cells. ACS Synth Biol 2022. [PMID: 36162812 DOI: 10.1021/acssynbio.2c00156] [Reference Citation Analysis]
2 Wang K, Escobar M, Li J, Mahata B, Goell J, Shah S, Cluck M, Hilton IB. Systematic comparison of CRISPR-based transcriptional activators uncovers gene-regulatory features of enhancer-promoter interactions. Nucleic Acids Res 2022:gkac582. [PMID: 35849129 DOI: 10.1093/nar/gkac582] [Reference Citation Analysis]
3 Bashor CJ, Hilton IB, Bandukwala H, Smith DM, Veiseh O. Engineering the next generation of cell-based therapeutics. Nat Rev Drug Discov. [DOI: 10.1038/s41573-022-00476-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Qin Y, Li S, Li XJ, Yang S. CRISPR-Based Genome-Editing Tools for Huntington's Disease Research and Therapy. Neurosci Bull 2022. [PMID: 35608753 DOI: 10.1007/s12264-022-00880-3] [Reference Citation Analysis]
5 Gardin A, Remih K, Gonzales E, Andersson ER, Strnad P. Modern therapeutic approaches to liver-related disorders. J Hepatol 2022;76:1392-409. [PMID: 35589258 DOI: 10.1016/j.jhep.2021.12.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang D, Wang Z, Jin M, Lin M, Wang N. CRISPR/Cas9-based genome editing for the modification of multiple duplications that cause Duchenne muscular dystrophy. Gene Ther. [DOI: 10.1038/s41434-022-00336-3] [Reference Citation Analysis]
7 Siddeek B, Simeoni U. Epigenetics provides a bridge between early nutrition and long-term health and a target for disease prevention. Acta Paediatr 2022;111:927-34. [PMID: 35038770 DOI: 10.1111/apa.16258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Prokhorova D, Zhukova Eschenko N, Lemza A, Sergeeva M, Amirkhanov R, Stepanov G. Application of the CRISPR/Cas9 System to Study Regulation Pathways of the Cellular Immune Response to Influenza Virus. Viruses 2022;14:437. [PMID: 35216030 DOI: 10.3390/v14020437] [Reference Citation Analysis]
9 van de Kooij B, van Attikum H. Genomic Reporter Constructs to Monitor Pathway-Specific Repair of DNA Double-Strand Breaks. Front Genet 2022;12:809832. [DOI: 10.3389/fgene.2021.809832] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bloomer H, Khirallah J, Li Y, Xu Q. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells. Adv Drug Deliv Rev 2022;181:114087. [PMID: 34942274 DOI: 10.1016/j.addr.2021.114087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
11 Shin H, Choi WL, Lim JY, Huh JH. Epigenome editing: targeted manipulation of epigenetic modifications in plants. Genes Genomics 2022. [PMID: 35000141 DOI: 10.1007/s13258-021-01199-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Thumfart KM, Jawaid A, Bright K, Flachsmann M, Mansuy IM. Epigenetics of childhood trauma: Long term sequelae and potential for treatment. Neurosci Biobehav Rev 2021:S0149-7634(21)00484-X. [PMID: 34742726 DOI: 10.1016/j.neubiorev.2021.10.042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Jia B, Han X, Kim KH, Jeon CO. Discovery and mining of enzymes from the human gut microbiome. Trends Biotechnol 2021:S0167-7799(21)00138-4. [PMID: 34304905 DOI: 10.1016/j.tibtech.2021.06.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]